Showing results (451-460 of 1,991) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|November 15, 2025
The evolving therapeutic landscape of dementia with Lewy bodiesLorraine V Kaila, Manabu Ikeda, Janet Sultana, et al.The Lancet. Neurology|December 13, 2025
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trialJulia C Greenland, Kerry Dresser, Emma Cutting, et al.The Lancet. Neurology|May 23, 2025
A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature InitiativeGeoffrey T Manley, Kristen Dams-O'Connor, Michael L Alosco, et al.The Lancet. Neurology|July 19, 2025
Safety and effectiveness of the Walk 'n Watch structured, progressive exercise protocol delivered by physical therapists for inpatient stroke rehabilitation in Canada: a phase 3, multisite, pragmatic, stepped-wedge, cluster-randomised controlled trialSue Peters, Stanley H Hung, Mark T Bayley, et al.The Lancet. Neurology|October 18, 2025
High-sensitivity C-reactive protein, LDL cholesterol, lipoprotein(a) and 30-year risk of stroke in healthy women: a prospective, longitudinal cohort studyAsk T Nordestgaard, M Vinayaga Moorthy, Nancy R Cook, et al.The Lancet. Neurology|August 16, 2025
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trialThomas O Crawford, Laurent Servais, Eugenio Mercuri, et al.The Lancet. Neurology|August 16, 2025
Advances in the classification and management of idiopathic inflammatory myopathiesJoost Raaphorst, Anneke J van der Kooi, Christopher A Mecoli, et al.The Lancet. Neurology|June 20, 2025
Friedreich's ataxia-a rare multisystem diseaseKathrin Reetz, Stella A Lischewski, Imis Dogan, et al.The Lancet. Neurology|June 20, 2025
Management of reproductive risks in people with epilepsyMarte Helene Bjørk, Cristine Cukiert, Bruna Nucera, et al.Pageof 200